Inventor · disambiguated record
Christopher Hulme
Also filed as: HULME CHRISTOPHER
13 granted patents·4 pending applications·264 citations·filing 1998–2024
91Inventor score
Files withAMGEN INC7UNIV ARIZONA5AVENTIS PHARMA LTD2AVENTIS PHARAMACEUTICALS INC1RHONE POULENC RORER LTD1
Top patents by PatentIndex Score
17 records- 0195US6800645B1Substituted azabicyclic compoundsAVENTIS PHARMA LTD·Filed 2000·Granted Oct 5, 2004·119 cites·11 claims
- 0289US6303600B1Substituted azabicyclic compoundsRHONE POULENC RORER LTD·Filed 1998·Granted Oct 16, 2001·68 cites·38 claims
- 0388US7329675B2Substituted azabicyclic compoundsAVENTIS PHARMA LTD·Filed 2004·Granted Feb 12, 2008·27 cites·15 claims
- 0481US6492553B1Methods for preparing N-[(aliphatic or aromatic)carbonyl)]-2-aminoaetamide compounds and for cyclizing such compoundsAVENTIS PHARAMACEUTICALS INC·Filed 1999·Granted Dec 10, 2002·34 cites·53 claims
- 0578US7544803B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2005·Granted Jun 9, 2009·3 cites·4 claims
- 0677US7144888B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2003·Granted Dec 5, 2006·9 cites·25 claims
- 0772US7148221B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2005·Granted Dec 12, 2006·1 cites·19 claims
- 0871US2025051325A1Small molecule inhibitors of dyrk/clk and uses thereofUNIV ARIZONA·Filed 2024·Application pending·0 cites
- 0968US2025382277A1Small molecule inhibitors of dyrk/clk and uses thereofUNIV ARIZONA·Filed 2023·Application pending·0 cites
- 1068US2025382301A1Small molecule inhibitors of dyrk/clk and uses thereofUNIV ARIZONA·Filed 2023·Application pending·0 cites
- 1165US12054483B2Small molecule inhibitors of DYRK/CLK and uses thereofUNIV ARIZONA·Filed 2019·Granted Aug 6, 2024·0 cites·1 claims
- 1264US7514438B2Melanin concentrating hormone receptor antagonistAMGEN INC·Filed 2004·Granted Apr 7, 2009·2 cites·9 claims
- 1363US10730842B2Small molecule inhibitors of DYRK1A and uses thereofUNIV ARIZONA·Filed 2016·Granted Aug 4, 2020·1 cites·10 claims
- 1459US7659276B2Melanin concentrating hormone receptor antagonistAMGEN INC·Filed 2009·Granted Feb 9, 2010·0 cites·8 claims
- 1554US7332511B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2005·Granted Feb 19, 2008·0 cites·19 claims
- 1643US2005256161A1Melanin concentrating hormone receptor antagonistsTEMPEST PAUL A·Filed 2004·Application pending·0 cites
- 1738US7553848B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2005·Granted Jun 30, 2009·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when Christopher Hulme files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →